MarketsandMarkets Gen-Next Probiotics and Microbiome Congress

February 6 - 7, 2020 | Sheraton San Diego Hotel & Marina
CONFERENCE SPEAKERS
Advisors
David Kyle
David Kyle
Executive Chairman and CSO,
Evolve BioSystems, Inc


Dr. Kyle, a 35-year veteran of biotechnology has co-founded biotech companies in the field of infant nutrition including Martek Biosciences. At Martek, he led R&D and Commercial Development for over 15 years and today Martek’s DHA and ARA are now found in virtually every infant formula around the world. In 2000 he co-founded the US Chapter of the Mother and Child Foundation, an organization headquartered in London dedicated to better health of pregnant women and their children through better nutrition.  In 2013, David joined Evolve BioSystems as CEO and led the Company through several private equity financings and became Chairman of the Board in 2017.  David combines a distinguished scientific background with commercial acumen, has published over 70 scientific articles, edited two books, is the named inventor on over 200 patents, and was inducted into the US Technology Hall of Fame in 2009, for his contributions to Science and Industry.


Masi Rajabi
Masi Rajabi
Director of Microbiology,
Nephron Pharmaceuticals



Dawn Bowdish
Dawn Bowdish
Assistant Professor,
McMaster University



Maya Ivanjesku
Maya Ivanjesku
Chief Scientific Officer,
Dakota Biotech


Maya holds Master of Science in Chemistry from Polytechnic University Brooklyn, NY. She has dedicated over twenty years of her career to the pharmaceutical, cosmeceutical and biotech industries formulating and launching products to market. Prior to creating LaFlore®, Maya held key senior leadership and R&D product development positions at many leading brands in the skincare industry, including: Estée Lauder, Clinique, Bobbi Brown, Origins, Aveda, TooFaced, Laura Mercier, Urban Decay, Smashbox, Nars, Benefit, MAC, Arbonne and many more.

Her expertise in manufacturing, quality and technology have been a great base in establishing Dakota Biotech’s own manufacturing facility, implementing quality systems and creating patented technologies.


Bharath Prithiviraj
Bharath Prithiviraj
Senior Scientist,
City university of New York



Speakers
Shailendra Singh (Shelly)
Shailendra Singh (Shelly)
Chief Operating Officer,
MarketsandMarkets


Shailendra Singh (Shelly) is Chief Operating Officer of MnM and a member of its board. He focuses on global sales and client services functions, as well as commercial optimization at MarketsandMarkets. He has years of expe¬rience in global delivery and outsourcing sector in the IT/ Consulting/Analytics/Big Data sectors. Prior to MnM, he was leading the global sales, client services and commercial ef¬fectiveness functions for Mu Sigma, a unicorn company and a leading global provider of Decision Sciences and Big Data analytics solutions.


Maya Ivanjesku
Maya Ivanjesku
Chief Scientific Officer,
Dakota Biotech


Maya holds Master of Science in Chemistry from Polytechnic University Brooklyn, NY. She has dedicated over twenty years of her career to the pharmaceutical, cosmeceutical and biotech industries formulating and launching products to market. Prior to creating LaFlore®, Maya held key senior leadership and R&D product development positions at many leading brands in the skincare industry, including: Estée Lauder, Clinique, Bobbi Brown, Origins, Aveda, TooFaced, Laura Mercier, Urban Decay, Smashbox, Nars, Benefit, MAC, Arbonne and many more.

Her expertise in manufacturing, quality and technology have been a great base in establishing Dakota Biotech’s own manufacturing facility, implementing quality systems and creating patented technologies.


Michael Bush
Michael Bush
President & CEO,
Prenexus Health



Xue Liang
Xue Liang
Microbiome Scientist,
Merck Exploratory Science Center



Rong Diao
Rong Diao
Sr. Microbiologist,
Klus Pharma



Chris Callewaert
Chris Callewaert
Postdoctoral Research Fellow,
Knight lab at University of California



Ross Youngs
Ross Youngs
CEO & Founder,
Biosortia Pharmaceuticals


Ross O. Youngs, Founder and CEO - Mr. Youngs has over 30 years of inventing products, technologies and processes for a variety of industries. Mr. Youngs holds over 75 patents worldwide and is driven to innovate by a focus on better, faster and less expensive. Recent major innovations have included an R&D 100 Award for collaboration on biopolymer technologies. In 2009, the Company was awarded a $6 million ARPA-E (U.S. Dept. of Energy R&D) grant for its algal harvesting technology which helped lead to the development of Biosortia’s drug discovery platform. In 1998, Mr. Youngs was awarded the Ernst & Young Ohio Entrepreneur of the Year award and the U.S. Small Business Administration honored Mr. Youngs as their national “Business Person of the Year” in a presentation made by Vice President Al Gore. 


Sanjeev Anand
Sanjeev Anand
Global Business Development,
Dechra Pharmaceuticals PLC



Bharath Prithiviraj
Bharath Prithiviraj
Senior Scientist,
City university of New York



Peter Leighton
Peter Leighton
CEO,
ProSperity Bioscience



Seth Crosby
Seth Crosby
Director, Research Collaborations,
Washington University School of Medicine


Seth Crosby is the Director of Science Collaboration in the Department of Genetics at Washington University.  Crosby works with groups within and outside the University to leverage technology to achieve research and clinical goals.  He has been at Washington University for 16 years. During that time, he directed the Department of Genetics Microarray Core, which is now part of GTAC and then GTAC, itself, during its first two years.  Prior to that he was the Director of Translational Research at the Genome Center (now the McDonnell Genome Institute). Prior to his tenure at Washington University, Dr. Crosby worked in the field of genomics and drug discovery at Abbott Laboratories, Pfizer and Pharmacia.


Jennie Starr
Jennie Starr
Director of Marketing ,
BioForm Solutions



Momchilo Vuyisich
Momchilo Vuyisich
Founder and Chief Science Officer,
Viome, Inc



Larry Weiss
Larry Weiss
CEO and Founder,
Persona Biome, Inc.



Juan Patarroyo
Juan Patarroyo
Scientific Technical Lead ,
Novartis Institutes for BioMedical Research (NIBR)



Eric Huang
Eric Huang
Professor,
University of California San Diego



Chuck Collins
Chuck Collins
Professor,
East Tennessee State University



Joseph C Ellis
Joseph C Ellis
Sr. Staff Scientist ,
OAK Ridge National Laboratory



Aubrey Levitt
Aubrey Levitt
CEO/Co-Founder,
Postbiotics +



M. Andrea Azcarate-Peril
M. Andrea Azcarate-Peril
Director, Microbiome Core Facility,
University of North Carolina



Arun Bhunia
Arun Bhunia
Professor of Food Microbiology,
Purdue University



A. Bruce Johnson
A. Bruce Johnson
PhD, Corporate Vice President, Business Development,
Animal Health Corporation



Michael Leonidas Chikindas
Michael Leonidas Chikindas
Microbiologist,
Rutgers University



Katrine Whiteson
Katrine Whiteson
Associate Director, UCI Microbiome Initiative,
University of California



Elliot Friedman
Elliot Friedman
Senior Research Investigator,
University of Pennsylvania


Dr. Friedman is a Senior Research Investigator in the Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania and the Technical Director of the Microbial Culture & Metabolomics Core of the PennCHOP Microbiome Program, a campus-wide initiative to accelerate research in the microbiome. The Microbial Culture & Metabolomics Core provides anaerobic and aerobic microbiology services to support basic and translational research studies, as well as targeted metabolomics analyses utilizing ultra-performance liquid chromatography/mass spectrometry. Dr. Friedman’s research on host-microbiota interactions includes the dynamics of molecular oxygen at the intestinal mucosal interface, the bile acid driven host-microbiota interaction in the small intestine, phytochemical metabolism by the gut microbiota, in-vitro models of the human gut microbiota, the dysbiotic microbiota in inflammatory bowel disease, and physiochemical factors driving microbial colonization of the infant gut.